Tweets by @cellcentric

Delighted to welcome Del to our growing clinical ops team, based at @AlderleyPark. Helping coordinate our CCS1477 oncology clinical trials. pic.twitter.com/Mz1dhL9Gdc

Targeting p300/CBP: mechanisms of action through to applications. CCS1477 in patients to treat specific cancer types: cellcentric.com/updates/blog-n… pic.twitter.com/vrftQ8ybVu

Some cancers have mutations in p300 or CBP. They can be targeted through paralogue lethality. More on p300/CBP: cellcentric.com/updates/blog-n… pic.twitter.com/UzigYEjcsE

Our clinical team continues to expand. Welcome Oliver! Supporting clinical testing of CCS1477 to treat multiple cancer types. pic.twitter.com/NaQFiOlrb3

Targeting twin proteins p300 and CBP to treat cancer: cellcentric.com/updates/blog-n… CCS1477, first of its kind drug, in the clinic. pic.twitter.com/c4iv3mUmYc

Read our blog to find out how targeting twin proteins p300 and CBP offers a new way to treat cancer: cellcentric.com/updates/blog-n… pic.twitter.com/1GCLclFLyS